BIOMAT Database Logo BIOMAT Database Logo

9-[2-(Phosphonomethoxy)propyl]adenine therapy of established simian immunodeficiency virus infection in infant rhesus macaques. 1996

K K Van Rompay, and J M Cherrington, and M L Marthas, and C J Berardi, and A S Mulato, and A Spinner, and R P Tarara, and D R Canfield, and S Telm, and N Bischofberger, and N C Pedersen
California Regional Primate Research Center, University of California, Davis 95616, USA. kkvanrompay@ucdavis.edu

The long-term therapeutic and toxic effects of 9-[2-(phosphonomethoxy)propyl]adenine (PMPA) were evaluated in simian immunodeficiency virus (SIV)-infected newborn rhesus macaques. Four untreated SIV-infected newborn macaques developed persistently high levels of viremia, and three of the four animals had rapidly fatal disease within 3 months. In contrast, long-term PMPA treatment of four newborn macaques starting 3 weeks after virus inoculation resulted in a rapid, pronounced, and persistent reduction of viremia in three of the four animals. Emergence of virus with fivefold-decreased susceptibility to PMPA occurred in all four PMPA-treated animals and was associated with the development of a lysine-to-arginine substitution at amino acid 65 (K65R mutation) and additional mutations in the reverse transcriptase; however, the clinical implications of this low-level drug resistance are nuclear. No toxic side effects have been seen, and all PMPA-treated animals have remained disease-free for more than 13 months. Our data suggest that PMPA holds much promise for the treatment of human immunodeficiency virus-infected human infants and adults.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D008253 Macaca mulatta A species of the genus MACACA inhabiting India, China, and other parts of Asia. The species is used extensively in biomedical research and adapts very well to living with humans. Chinese Rhesus Macaques,Macaca mulatta lasiota,Monkey, Rhesus,Rhesus Monkey,Rhesus Macaque,Chinese Rhesus Macaque,Macaca mulatta lasiotas,Macaque, Rhesus,Rhesus Macaque, Chinese,Rhesus Macaques,Rhesus Macaques, Chinese,Rhesus Monkeys
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D009943 Organophosphorus Compounds Organic compounds that contain phosphorus as an integral part of the molecule. Included under this heading is broad array of synthetic compounds that are used as PESTICIDES and DRUGS. Organophosphorus Compound,Organopyrophosphorus Compound,Organopyrophosphorus Compounds,Compound, Organophosphorus,Compound, Organopyrophosphorus,Compounds, Organophosphorus,Compounds, Organopyrophosphorus
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D004351 Drug Resistance Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. Resistance, Drug
D000068698 Tenofovir An adenine analog REVERSE TRANSCRIPTASE INHIBITOR with antiviral activity against HIV-1 and HEPATITIS B. It is used to treat HIV INFECTIONS and CHRONIC HEPATITIS B, in combination with other ANTIVIRAL AGENTS, due to the emergence of ANTIVIRAL DRUG RESISTANCE when it is used alone. (R)-9-(2-phosphonylmethoxypropyl)adenine,9-(2-Phosphonomethoxypropyl)adenine,9-(2-Phosphonylmethoxypropyl)adenine,9-(2-Phosphonylmethoxypropyl)adenine, (+-)-isomer,9-(2-Phosphonylmethoxypropyl)adenine, (R)-isomer - T357098,9-(2-Phosphonylmethoxypropyl)adenine, (S)-isomer,9-PMPA (tenofovir),Tenofovir Disoproxil,Tenofovir Disoproxil Fumarate,Viread,Disoproxil Fumarate, Tenofovir,Disoproxil, Tenofovir,Fumarate, Tenofovir Disoproxil
D000225 Adenine A purine base and a fundamental unit of ADENINE NUCLEOTIDES. Vitamin B 4,4, Vitamin B,B 4, Vitamin
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000831 Animals, Newborn Refers to animals in the period of time just after birth. Animals, Neonatal,Animal, Neonatal,Animal, Newborn,Neonatal Animal,Neonatal Animals,Newborn Animal,Newborn Animals

Related Publications

K K Van Rompay, and J M Cherrington, and M L Marthas, and C J Berardi, and A S Mulato, and A Spinner, and R P Tarara, and D R Canfield, and S Telm, and N Bischofberger, and N C Pedersen
Administration of 9-[2-(phosphonomethoxy)propyl]adenine (PMPA) for prevention of perinatal simian immunodeficiency virus infection in rhesus macaques.
June 1998, AIDS research and human retroviruses,
K K Van Rompay, and J M Cherrington, and M L Marthas, and C J Berardi, and A S Mulato, and A Spinner, and R P Tarara, and D R Canfield, and S Telm, and N Bischofberger, and N C Pedersen
Biological effects of short-term or prolonged administration of 9-[2-(phosphonomethoxy)propyl]adenine (tenofovir) to newborn and infant rhesus macaques.
May 2004, Antimicrobial agents and chemotherapy,
K K Van Rompay, and J M Cherrington, and M L Marthas, and C J Berardi, and A S Mulato, and A Spinner, and R P Tarara, and D R Canfield, and S Telm, and N Bischofberger, and N C Pedersen
Administration of 9-[2-(R)-(phosphonomethoxy)propyl]adenine (PMPA) to gravid and infant rhesus macaques (Macaca mulatta): safety and efficacy studies.
April 1999, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association,
K K Van Rompay, and J M Cherrington, and M L Marthas, and C J Berardi, and A S Mulato, and A Spinner, and R P Tarara, and D R Canfield, and S Telm, and N Bischofberger, and N C Pedersen
Preexposure prophylaxis with 9-(2-phosphonylmethoxyethyl)adenine against simian immunodeficiency virus infection in macaques.
February 1994, The Journal of infectious diseases,
K K Van Rompay, and J M Cherrington, and M L Marthas, and C J Berardi, and A S Mulato, and A Spinner, and R P Tarara, and D R Canfield, and S Telm, and N Bischofberger, and N C Pedersen
Efficacy of 9-(2-phosphonylmethoxyethyl)adenine treatment against chronic simian immunodeficiency virus infection in macaques.
May 1995, The Journal of infectious diseases,
K K Van Rompay, and J M Cherrington, and M L Marthas, and C J Berardi, and A S Mulato, and A Spinner, and R P Tarara, and D R Canfield, and S Telm, and N Bischofberger, and N C Pedersen
Role of rhesus macaque IFITM3(2) in simian immunodeficiency virus infection of macaques.
January 2019, PloS one,
K K Van Rompay, and J M Cherrington, and M L Marthas, and C J Berardi, and A S Mulato, and A Spinner, and R P Tarara, and D R Canfield, and S Telm, and N Bischofberger, and N C Pedersen
Vaccine protection of rhesus macaques against simian immunodeficiency virus infection.
November 1990, AIDS research and human retroviruses,
K K Van Rompay, and J M Cherrington, and M L Marthas, and C J Berardi, and A S Mulato, and A Spinner, and R P Tarara, and D R Canfield, and S Telm, and N Bischofberger, and N C Pedersen
Neuropathogenesis of chimeric simian human immunodeficiency virus infection in rhesus macaques.
August 2000, Journal of medical primatology,
K K Van Rompay, and J M Cherrington, and M L Marthas, and C J Berardi, and A S Mulato, and A Spinner, and R P Tarara, and D R Canfield, and S Telm, and N Bischofberger, and N C Pedersen
Simian Virus 40 Infection in the Spinal Cord of Simian Immunodeficiency Virus-Immunosuppressed Rhesus Macaques.
November 2015, Journal of neuropathology and experimental neurology,
K K Van Rompay, and J M Cherrington, and M L Marthas, and C J Berardi, and A S Mulato, and A Spinner, and R P Tarara, and D R Canfield, and S Telm, and N Bischofberger, and N C Pedersen
Plasma proteomic analysis of simian immunodeficiency virus infection of rhesus macaques.
September 2010, Journal of proteome research,
Copied contents to your clipboard!